Insider trading

Period: 120 months Stock: RNAC Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

32 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

32 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

32 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

32 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
32 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
32 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

32 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Dec 2025
BARABE TIMOTHY C Director
Bought
$205.80K 30,000 at 6.86
123%
Largest buy in 3 yrs
15 Nov 2024
Miljkovic Milos Chief Medical Officer
Sold at will
$342.89K 20,000 at 17.14
52.3%
Sold half or more
14 Nov 2024
Jewell Christopher M Chief Scientific Officer
Sold at will 2×
$600.95K 36,050 at 16.67
58.2%
Sold half or more
14 Nov 2024
Miljkovic Milos Chief Medical Officer
Sold at will
$564.64K 35,000 at 16.13
65.7%
Sold half or more
12 Aug 2024
SPRINGER TIMOTHY A Director · indirect
Bought
$101.97K 8,016 at 12.72
229%
+229% of stake
12 Aug 2024
BARABE TIMOTHY C Director
Bought
$95.25K 7,500 at 12.70
52.6%
Largest buy in 3 yrs
13 Jun 2022
COX CARRIE SMITH Director
Bought
$149.80K 130,000 at 1.15
157%
Largest buy in 3 yrs
13 Aug 2019
BARABE TIMOTHY C Director
Bought
$17.20K 10,000 at 1.72
133%
First buy on file
25 Jan 2019
Bought
$6.00M 4,000,000 at 1.50
876%
First buy on file
25 Jan 2019
Nashat Amir Director · indirect
Bought 4×
$1.75M 1,166,666 at 1.50
77.3%
First buy on file
25 Jan 2019
SPRINGER TIMOTHY A Director · indirect
Bought
$100.00K 66,666 at 1.50
684%
First buy on file
10 Nov 2017
SPRINGER TIMOTHY A Director · indirect
Bought
$42.91K 4,752 at 9.03
95.0%
First buy on file
10 Nov 2017
BARABE TIMOTHY C Director
Bought
$22.50K 2,500 at 9.00
50.1%
First buy on file
9 Nov 2017
BARABE TIMOTHY C Director
Bought
$24.34K 2,500 at 9.73
100%
First buy on file
26 Sep 2017
Nashat Amir Director · indirect
Sold, plan not stated 4×
$1.33M 70,226 at 18.91
86.9%
Sold half or more
25 Sep 2017
Nashat Amir Director · indirect
Sold, plan not stated 4×
$705.88K 37,175 at 18.99
77.0%
Sold half or more
22 Sep 2017
Nashat Amir Director · indirect
Sold, plan not stated 4×
$809.78K 42,036 at 19.26
78.8%
Sold half or more
21 Sep 2017
Nashat Amir Director · indirect
Sold, plan not stated 4×
$2.08M 104,577 at 19.86
90.0%
Sold half or more
20 Sep 2017
Nashat Amir Director · indirect
Sold, plan not stated 4×
$853.39K 42,610 at 20.03
77.6%
Sold half or more
20 Sep 2017
Siewers David CFO and Treasurer
Sold, plan not stated 2×
$328.48K 16,424 at 20.00
100%
Sold half or more
3 Jul 2017
Johnston Lloyd P. COO and SVP, R*D
Sold, plan not stated 2×
$113.81K 5,959 at 19.10
78.8%
Sold half or more
30 Jun 2017
Siewers David Chief Financial Officer
Sold, plan not stated
$148.41K 7,420 at 20.00
100%
Sold half or more
29 Jun 2017
Siewers David Chief Financial Officer
Sold, plan not stated 2×
$193.04K 9,652 at 20.00
100%
Sold half or more
27 Jun 2017
Bought
$6.00M 338,791 at 17.71
×20
First buy on file
27 Jun 2017
Keller Peter Chief Business Officer
Sold, plan not stated
$88.68K 4,595 at 19.30
91.9%
Sold half or more
26 Jun 2017
Siewers David Chief Financial Officer
Sold, plan not stated
$137.72K 6,886 at 20.00
99.5%
Sold half or more
15 Jun 2017
Johnston Lloyd P. COO and SVP, R*D
Sold, plan not stated
$348.64K 20,512 at 17.00
92.7%
Sold half or more
17 Apr 2017
Johnston Lloyd P. COO AND SVP, R&D
Sold, plan not stated
$184.21K 13,205 at 13.95
89.2%
Sold half or more
23 Jan 2017
Johnston Lloyd P. COO AND SVP, R&D
Sold, plan not stated 2×
$210.11K 15,000 at 14.01
90.3%
Sold half or more
28 Dec 2016
Kishimoto Takashi Kei Chief Scientific Officer
Sold, plan not stated
$175.50K 10,000 at 17.55
100%
Sold half or more
21 Dec 2016
Abraham David CCO, Gen.Counsel, Corp.Sec.
Sold, plan not stated
$267.19K 14,844 at 18.00
100%
Sold half or more
19 Dec 2016
Keller Peter Chief Business Officer
Sold, plan not stated
$87.75K 4,723 at 18.58
92.1%
Sold half or more
Showing 1–32 of 32.